These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 32205444)

  • 1. 15-Epi-LXA
    Sekheri M; El Kebir D; Edner N; Filep JG
    Proc Natl Acad Sci U S A; 2020 Apr; 117(14):7971-7980. PubMed ID: 32205444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-β regulates proresolving lipids to promote the resolution of acute airway inflammation.
    Sekheri M; Rizo-Téllez SA; Othman A; El Kebir D; Filep JG
    Proc Natl Acad Sci U S A; 2022 Aug; 119(31):e2201146119. PubMed ID: 35878041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin-triggered resolvin D1 reduces pneumococcal lung infection and inflammation in a viral and bacterial coinfection pneumonia model.
    Wang H; Anthony D; Yatmaz S; Wijburg O; Satzke C; Levy B; Vlahos R; Bozinovski S
    Clin Sci (Lond); 2017 Sep; 131(18):2347-2362. PubMed ID: 28779028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin-triggered resolvin D1 is produced during self-resolving gram-negative bacterial pneumonia and regulates host immune responses for the resolution of lung inflammation.
    Abdulnour RE; Sham HP; Douda DN; Colas RA; Dalli J; Bai Y; Ai X; Serhan CN; Levy BD
    Mucosal Immunol; 2016 Sep; 9(5):1278-87. PubMed ID: 26647716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 15-epi-lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury.
    El Kebir D; József L; Pan W; Wang L; Petasis NA; Serhan CN; Filep JG
    Am J Respir Crit Care Med; 2009 Aug; 180(4):311-9. PubMed ID: 19483113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues.
    Takano T; Clish CB; Gronert K; Petasis N; Serhan CN
    J Clin Invest; 1998 Feb; 101(4):819-26. PubMed ID: 9466977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for an anti-inflammatory loop centered on polymorphonuclear leukocyte formyl peptide receptor 2/lipoxin A4 receptor and operative in the inflamed microvasculature.
    Brancaleone V; Dalli J; Bena S; Flower RJ; Cirino G; Perretti M
    J Immunol; 2011 Apr; 186(8):4905-14. PubMed ID: 21398608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors.
    Takano T; Fiore S; Maddox JF; Brady HR; Petasis NA; Serhan CN
    J Exp Med; 1997 May; 185(9):1693-704. PubMed ID: 9151906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the lipoxin A4 and resolvin D1 receptor impairs host response to acute lung injury caused by pneumococcal pneumonia in mice.
    Siegel ER; Croze RH; Fang X; Matthay MA; Gotts JE
    Am J Physiol Lung Cell Mol Physiol; 2021 Jun; 320(6):L1085-L1092. PubMed ID: 33822656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resolvin D1-mediated NOX2 inactivation rescues macrophages undertaking efferocytosis from oxidative stress-induced apoptosis.
    Lee HN; Surh YJ
    Biochem Pharmacol; 2013 Sep; 86(6):759-69. PubMed ID: 23856291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent.
    Orr SK; Colas RA; Dalli J; Chiang N; Serhan CN
    Am J Physiol Lung Cell Mol Physiol; 2015 May; 308(9):L904-11. PubMed ID: 25770181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of activity of 15-epi-lipoxin A₄ on FPR2/ALX and CysLT1 receptors in interleukin-8-driven human neutrophil function.
    Planagumà A; Domenech T; Jover I; Ramos I; Sentellas S; Malhotra R; Miralpeix M
    Clin Exp Immunol; 2013 Aug; 173(2):298-309. PubMed ID: 23607720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages.
    Godson C; Mitchell S; Harvey K; Petasis NA; Hogg N; Brady HR
    J Immunol; 2000 Feb; 164(4):1663-7. PubMed ID: 10657608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin-triggered lipoxin A4 (15-epi-LXA4) increases the endothelial viability of human corneas storage in Optisol-GS.
    He J; Kakazu AH; Bazan NG; Bazan HE
    J Ocul Pharmacol Ther; 2011 Jun; 27(3):235-41. PubMed ID: 21548792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs.
    Krishnamoorthy S; Recchiuti A; Chiang N; Fredman G; Serhan CN
    Am J Pathol; 2012 May; 180(5):2018-27. PubMed ID: 22449948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli-driven acute inflammation.
    Motwani MP; Colas RA; George MJ; Flint JD; Dalli J; Richard-Loendt A; De Maeyer RP; Serhan CN; Gilroy DW
    JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor.
    Dalli J; Consalvo AP; Ray V; Di Filippo C; D'Amico M; Mehta N; Perretti M
    J Immunol; 2013 Jun; 190(12):6478-87. PubMed ID: 23686496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function.
    Kain V; Ingle KA; Colas RA; Dalli J; Prabhu SD; Serhan CN; Joshi M; Halade GV
    J Mol Cell Cardiol; 2015 Jul; 84():24-35. PubMed ID: 25870158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 15-epi-Lipoxin A
    Sham HP; Walker KH; Abdulnour RE; Krishnamoorthy N; Douda DN; Norris PC; Barkas I; Benito-Figueroa S; Colby JK; Serhan CN; Levy BD
    J Immunol; 2018 Apr; 200(8):2757-2766. PubMed ID: 29523657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoxin and synthetic lipoxin analogs: an overview of anti-inflammatory functions and new concepts in immunomodulation.
    Parkinson JF
    Inflamm Allergy Drug Targets; 2006 Apr; 5(2):91-106. PubMed ID: 16613568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.